p38 mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest

Molecular Biology of the Cell

Volumn 14, Issue 5, 2003, Pages 2071-2087

  Deacon, Karl ^a,c   Mistry, Pratibha ^a   Chernoff, Jonathan ^b   Blank, Jonathan L ^a   Patel, Rajnikant ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b FOX CHASE CANCER CENTER   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; ANTINEOPLASTIC AGENT; CYTOCHALASIN D; DOMINANT ACTIVE MKK6; HISTONE H1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NOCODAZOLE; PACLITAXEL; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN P21; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CYTOSOL; HELA CELL; HUMAN; HUMAN CELL; MICROTUBULE; MITOCHONDRION; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STIMULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; CYTOPLASM; HELA CELLS; HUMANS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; MITOSIS; NOCODAZOLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

MAMMALIA;

EID: 0038247837     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-10-0653     Document Type: Article

References (57)

1. Aoshiba, K., Yasui, S., Hayashi, M., Tamaoki, J., and Nagai, A. (1999). Role of p38-mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils. J. Immunol. 162, 1692-1700.
2. Bagrodia, S., and Cerione, R.A. (1999). PAK to the future. Trends Cell Biol. 9, 350-355.
3. Bagrodia, S., Derijard, B., Davis, R.J., and Cerione, R.A. (1995). Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 270, 27995-27998.
4. Bueno, O.F., et al. (2000). The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. Cancer Res. 60, 5887-5894.
5. Burke, D. (2000). Complexity in the spindle checkpoint. Curr. Opin. Gen. Dev. 10, 26-31.
6. i-dependent activation. J. Biol. Chem. 275, 19395-19400.
7. Derijard, B., Raingeaud, J., Barrett, T., Wu, I.H., Han, J., Ulevitch, R.J., and Davis, R.J. (1995). Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 270, 7420-7426.
8. Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B., and Martinou, J.C. (1999). Bid-induced conformational change of Bax is responsible for mitochondrail cytochrome c release during apoptosis. J. Cell Biol. 144, 891-901.
9. 2-terminal kinases. J. Biol. Chem. 274, 16604-16610.
10. Deschesnes, R.G., Huot, J., Valerie, K., and Landry, J. (2001). Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol. Biol. Cell 12, 1569-1582.
11. Downward, J. (1999). How BAD phosphorylation is good for survival. Nat. Cell Biol. 1, E33-E35.
12. 2+ ions. J. Cell Biol. 143, 217-224.
13. Fang, G., Yu, H., and Kirschner, M.W. (1999). Control of mitotic transitions by the anaphase-promoting complex. Phil. Trans. R. Soc. Lond. B. Biol. Sci. 354, 1583-1590.
14. Faure, S., Vigneron, S., Doree, M., and Morin, N. (1997). A member of the Ste20/PAK family of protein kinases is involved in both arrest in Xenopus oocytes and G2/prophase of the first meiotic cell cycle and prevention of apoptosis. EMBO J. 16, 5550-5561.
15. Finucane, D.M., Bossy-Wetzel, E., Waterhouse, N.J., Cotter, T.G., and Green, D.R. (1999). Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274, 2225-2233.
16. Geley, S., Kramer, E., Gieffers, C., Gannon, J., Peters, J.M., and Hunt, T. (2001). Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153, 137-148.
17. Ghatan, S., Larner, S., Kinoshita, Y., Hetman, M., Patel, L., Xia, Z., Youle, R.J., and Morrison, R.S. (2000). p38 MAPK mediates Bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150, 335-347.
18. Gnesutta, N., Qu, J., and Minden, A. (2001). The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276, 14414-14419.
19. Hagemann, C., and Blank, J.L. (2001). The ups and downs of MEK kinase interactions. Cell Signal. 13, 863-875.
20. Hsu, Y.T., Wolter, K.G., and Youle, R.J. (1997). Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. USA 94, 3668-3672.
21. Jakobi, R., Moertl, E., and Koeppel, M.A. (2001). p21-activated protein kinase γ-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J. Biol. Chem. 276, 16624-16634.
22. Jiang, Y., Gram, H., Zhao, M., New, L., Gu, J., Feng, L., DiPadova, F., Ulevitch, R.J., and Han, J. (1997). Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ. J. Biol. Chem. 272, 30122-30128.
23. Jordan, M.A., Wendell, K., Gardiner, S., Derry, W.B., Copp, H., and Wilson, L. (1996). Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56, 816-825.
24. Jurgensmeier, J.M., Xie, Z., Devereaux, Q., Ellerby, L., Bredesen, D., and Reed, J.C. (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 4997-5002.
25. Kyriakis, J.M., and Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869.
26. Kummer, J.L., Rao, P.K., and Heidenreich, K.A. (1997). Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272, 20490-20494.
27. Kurokawa, H., Lenferink, A.E., Simpson, J.F., Pisacane, P.I., Sliwkowski, M.X., Forbes, J.T., and Arteaga, C.L. (2000). Inhibition of HER2/Neu (erbB-2) and mitogen-activated protein kinases enhance tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res. 60, 5887-5894.
28. Leers, M.P.G., et al. (1999). Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187, 567-572.
29. Lee, J.C., et al. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
30. Li, Y., and Benezra, R. (1996). Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246-248.
31. McDaid, H.M., and Horwitz, S.B. (2001). Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cell lines. Mol. Pharmacol. 60, 290-301.
32. Nechustan, A., Smith, C.L., Hsu, Y.T., and Youle, R.J. (1999). Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 273, 16415-16420.
33. Okano, J.-I., and Rustgi, A.K. (2001). Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery. J. Biol. Chem. 276, 19555-19564.
34. WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression. J. Cell Sci. 111, 2247-2255.
35. Patel, R., Holt, M., Philipova, R., Moss, S., Schulman, H., Hidaka, H., and Whitaker, M. (1999). Calcium/calmodulin-dependent phosphorylation and activation of human cdc25-C at the G2/M phase transition in HeLa cells. J. Biol. Chem. 274, 7958-7968.
36. Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M.J., Gjerset, R., and Mercola, D. (1997). The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272, 14041-14044.
37. Remacle-Bonnet, M.M., Garrouste, F.L., Heller, S., Andre, F., Marvaldi, J.L., and Pommier, G.J. (2000). Insulin-like growth factor-1 protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor α-induced mitogen-activated protein kinase and nuclear factor κB signaling pathways. Cancer Res. 60, 2007-2017.
38. Rowinsky, E.K., and Donehower, R.C. (1991). The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapy. Pharmacol. Ther. 52, 35-84.
39. Rudel, T., and Bokoch, G.M. (1997). Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574.
40. Schurmann, A., Mooney, A.F., Sanders, L.C., Sells, M.A., Wang, H.G., Reed, J.C., and Bokoch, G.M. (2000). P21-activated kinase 1 phosphorylares the death agonist Bad and protects cells from apoptosis. Mol. Cell. Biol. 20, 453-461.
41. Seidman, R., Gitelman, I., Sagi, O., Horwitz, S.B., and Wolfson, M. (2001). The role of erk1/2 and p38 MAP-kinase pathways in taxolinduced apoptosis in human ovarian carcinoma cells. Exp. Cell Res. 268, 84-92.
42. Shah, J.V., and Cleveland, D.W. (2000). Waiting for anaphase: Mad2 and the spindle assembly checkpoint. Cell 103, 997-1000.
43. Shtil, A.A., Mandlekar, S., Yu, R., Walter, R.J., Hagen, K., Tan, T.H., Roninson, I.B., and Kong, A.N. (1999). Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene 18, 377-384.
44. Sorger, P.K., Dobles, M., Tournebize, R., and Hyman, A.A. (1997). Coupling cell division and cell death to microtubule dynamics. Curr. Opin. Cell Biol. 9, 807-814.
45. Stadheim, T.A., Xiao, H., and Eastman, A. (2001). Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. Cancer Res. 61, 1533-1540.
46. Subbaramaiah, K., Hart, J.C., Norton, L., and Dannenberg, A.J. (2000). Microtubule-interfering agents stimulate the transcription of cyclo-oxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 275, 14838-14845.
47. Tang, Y., Zhou, S., Chen, A., Pittman, R.N., and Field, J. (2000). The Akt proto-oncogene links Ras to Pak and cell survival signals. J. Biol. Chem. 275, 9106-9109.
48. Tan, Y., Demeter, M.R., Ruan, H., and Comb, M.J. (2000). BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem. 275, 25865-25869.
49. Verheij, M., et al. (1996). Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380, 75-79.
50. Wang, T.H., Wang, H.S., Ichijo, H., Giannakakou, P., Foster, J.S., Fojo, T., and Wimalasena, J. (1998). Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273, 4928-4936.
51. Wang, T.H., Wang, H.S., and Soong, Y.K. (2000). Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88, 2619-2628.
52. Wilson, L., and Jordan, M.A. (1995). Microtubule dynamics: taking aim at a moving target. Chem. Biol. 2, 569-573.
53. Wolter, K.G., Hsu, Y-T., Smith, C.L., Nechustan, A., Xi, X.G., and Youle, R.J. (1997). Movement of bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292.
54. Woods, C.M., Zhu, J., McQuenet, P.A., Bollag, D., and Lazarides, E. (1995). Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1, 506-526.
55. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. (1995). Opposing effects of ERK and JNK-p38 MAPKs on apoptosis. Science 270, 1326-1331.
56. Xiang, J.G., Chao, D.T., and Korsmeyer, S.J. (1996). BAX-induced cell death may not require interleukin ILβ-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14559-14563.
57. 2-terminal kinase activation in response to changes in the microtubule cytoskeleton. J. Biol. Chem. 272, 12605-12610.